Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive — Morrow, Georgia

Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive is a clinical research site located in Morrow, Georgia, United States 30260.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive has participated in 1 clinical trials.

Therapeutic areas: Dry Eye Syndromes.

Sponsors: Senju Pharmaceutical Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Morrow

Browse all research sites in Georgia · View every site in Morrow

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive?

Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive conducted?

Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive has 1 clinical trials on record. Their work covers Dry Eye Syndromes.

Is Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive accredited by Crixeo Clinical Trials?

Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clayton Eye Center, Suite 100 and 120, 1000 Corporate Center Drive?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.